NEUWERK is a full-service law firm in Hamburg, Germany, serving national and international clients from start-ups and innovative mid-size enterprises to Fortune 500 companies. The firm provides legal advice on all IP and IT matters, including licensing and partnering, technology transfers, joint ventures and alliances, software and IT outsourcings, data protection and privacy, as well as complex commercial law matters.
Founded in 2016 as a spin-off from a magic circle firm, the practice has specialized on assisting clients from the life sciences and healthcare sector in particular. NEUWERK regularly advises biotechnology companies, pharmaceutical companies and medical device manufacturers on product divestitures, licensing arrangements, R&D collaborations, clinical trial agreements and distribution matters, as well as on numerous other issues relating to the development, manufacture and marketing of their products.
Börge Seeger heads the life sciences focus group at NEUWERK. His team recently advised the University Clinic of Cologne, Germany, on a global license and collaboration agreement with mRNA specialist BioNTech for the joint development of new approaches against HIV. He also recently advised multinational health care company Fresenius on all legal matters in connection with the global outsourcing of its central IT services, covering approximately 60,000 employees in more than 1,000 sites worldwide.
Clients regularly praise NEUWERK lawyers as "incredibly responsive” and “fun to work with”, Börge Seeger is praised by clients as “our go-to guy” for both IP and IT matters.
NEUWERK and its partners are highly recommended by all major ranking institutions including Legal 500, Chambers, JUVE, IAM, Best Lawyers and Who's Who Legal.
